Try our Advanced Search for more refined results
January 09, 2018
Federal Trade Commission v. Cellmark Biopharma, LLC et al
Case Number:
2:18-cv-00014
Court:
Nature of Suit:
Judge:
Government Agencies
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
January 10, 2018
Supplement Co., FTC Settle Cancer Treatment Product Suit
Florida dietary supplement company CellMark Biopharma LLC and its founder agreed to stop touting that two products were "clinically proven" to fight cancer-related malnutrition and cognitive impairment after the Federal Trade Commission said those claims weren't true.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login